Literature DB >> 2868877

Hypnotics. Their place in therapeutics.

A N Nicholson.   

Abstract

Sleep disturbance has become a subject of serious study only over the past few years, but even so there is already an increasing awareness of the nature of insomnia and a greater understanding of the role which hypnotics should play in clinical medicine. An hypnotic may be used to shorten sleep onset when there is difficulty in falling asleep, to reduce nocturnal wakefulness, or to provide an anxiolytic effect during the next day when insomnia is accompanied by a marked element of anxiety. The purpose of an hypnotic is to meet one or more of these clinical problems; to ensure that the patient is given the most useful medication, consideration must be given to duration of activity. This depends on the absorption, distribution and elimination characteristics of the drug. It is now appreciated that the most appropriate use of hypnotics is in the individual with insomnia of recent origin. An hypnotic with the most relevant pharmacokinetic profile should be used for the shortest period of time and then only as required, while low doses will ensure freedom from adverse effects. The place of hypnotics in chronic insomnia remains less certain. Their careful use may well be of benefit, though it must be part of a well defined clinical strategy. Assessment of the patient is essential to identify any specific conditions which would impair sleep.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2868877     DOI: 10.2165/00003495-198631020-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  23 in total

1.  Consensus conference. Drugs and insomnia. The use of medications to promote sleep.

Authors: 
Journal:  JAMA       Date:  1984-05-11       Impact factor: 56.272

Review 2.  Rebound insomnia and elimination half-life: assessment of individual subject response.

Authors:  E O Bixler; J D Kales; A Kales; J A Jacoby; C R Soldatos
Journal:  J Clin Pharmacol       Date:  1985-03       Impact factor: 3.126

3.  Pharmacokinetics and pharmacodynamics following single and repeated nightly administrations of loprazolam, a new benzodiazepine hypnotic.

Authors:  G T McInnes; E A Bunting; R M Ings; J Robinson; S I Ankier
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

4.  Effect of age and gender on disposition of temazepam.

Authors:  M Divoll; D J Greenblatt; J S Harmatz; R I Shader
Journal:  J Pharm Sci       Date:  1981-10       Impact factor: 3.534

5.  Oxazepam kinetics: effects of age and sex.

Authors:  D J Greenblatt; M Divoll; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

6.  Pharmacodynamic correlates of modified absorption: studies with lormetazepam.

Authors:  D M Pierce; R A Franklin; T V Harry; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

7.  Physiologic and temporal variation in hepatic elimination of midazolam.

Authors:  U Klotz; G Ziegler
Journal:  Clin Pharmacol Ther       Date:  1982-07       Impact factor: 6.875

8.  Pharmacokinetics and metabolism of zopiclone.

Authors:  J Gaillot; D Heusse; G W Hougton; J Marc Aurele; J F Dreyfus
Journal:  Pharmacology       Date:  1983       Impact factor: 2.547

9.  Imidazobenzodiazepines: sleep and performance studies in humans.

Authors:  A N Nicholson; B M Stone
Journal:  J Clin Psychopharmacol       Date:  1983-04       Impact factor: 3.153

10.  Comparative single-dose kinetics of oxazolam, prazepam, and clorazepate: three precursors of desmethyldiazepam.

Authors:  H R Ochs; D J Greenblatt; B Verburg-Ochs; A Locniskar
Journal:  J Clin Pharmacol       Date:  1984-10       Impact factor: 3.126

View more
  10 in total

1.  Hypnotics. Drug selection by means of the System of Objectified Judgement Analysis (SOJA) method.

Authors:  R Janknegt; A van der Kuy; G Declerck; C Idzikowski
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

2.  Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up.

Authors:  R van Hulten; H G Leufkens; A Bakker
Journal:  Pharm World Sci       Date:  1998-04

Review 3.  New drugs. Hypnotics and anxiolytics.

Authors:  B R Ballinger
Journal:  BMJ       Date:  1990-02-17

4.  Patients, prescribing, and benzodiazepines.

Authors:  L Nolan; K O'Malley
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  A practical guide to prescribing hypnotic benzodiazepines.

Authors:  M Lader
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

Review 6.  Problems and pitfalls in the use of benzodiazepines in the elderly.

Authors:  W H Kruse
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

Review 7.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

8.  Repeated dose effects of lormetazepam and flurazepam upon driving performance.

Authors:  K A Brookhuis; E R Volkerts; J F O'Hanlon
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 9.  Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.

Authors:  S I Ankier; K L Goa
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

10.  Treatment of insomnia with two benzodiazepines: a double-blind crossover study.

Authors:  K G Götestam; F Oppöyen; D Berntzen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.